Sunshine Biopharma, Inc. (SBFM) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -2.07M | -1.62M | -727.8K | -1.27M | -1.7M | -3.41M | -1.36M | -4.58M | -3.19M | -2.69M | -457.29K | -3.78M |
| Operating CF Margin % | -25.62% | -18.84% | -7.73% | -13.53% | -19.04% | -35.51% | -16.08% | -49.21% | -42.24% | -35.02% | -7.68% | -67.94% |
| Operating CF Growth % | -22.25% | 52.57% | 46.35% | 72.18% | 46.78% | -26.68% | -196.66% | -21.17% | -72.16% | -19.72% | 59.31% | -558.42% |
| Net Income | -1.24M | -2.14M | -883.82K | -1.77M | -1.18M | -2.16M | -1.2M | -494.3K | -1.28M | -1.25M | -651.48K | -902.11K |
| Depreciation & Amortization | 76.86K | 98.58K | 96.16K | 72.53K | 64.79K | 65.4K | 64.63K | 50.88K | 42.62K | 42.35K | 37.2K | 34.88K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 0 | 142.04K | 571.92K | 1.06M | 0 | -2.25M | 4.38K | -2.55M | 12K | 374 | 1.08M | -1.08M |
| Working Capital Changes | -905.09K | 284.3K | -512.07K | -636.94K | -580.02K | 937.57K | -227.79K | -1.59M | -1.96M | -1.48M | -926.8K | -1.83M |
| Change in Receivables | -609.6K | 41.29K | -649.85K | 65.71K | 426.67K | -1.02M | 986.99K | -1.77M | -536.26K | -475.66K | -63.32K | -191.05K |
| Change in Inventory | 78.4K | 772.8K | -1.29M | -555.08K | -568.83K | -1.8M | -1.25M | -848.85K | -2.1M | -1.14M | -335.87K | -467.93K |
| Change in Payables | -455.84K | -565.04K | 1.22M | -363.69K | -486.01K | 1.75M | -565.72K | 1.5M | 1.29M | -776.16K | 515.53K | -1.03M |
| Cash from Investing | -104.52K | -50.21K | -118.3K | -491.78K | -212.02K | -531.53K | -670.6K | -542.21K | -668.74K | -269.23K | 18.86K | -259.48K |
| Capital Expenditures | -104.52K | 175.53K | -8.04K | -160K | -7.49K | -444.13K | -517K | -974.51K | -62.94K | 382.36K | -9.63K | -294.23K |
| CapEx % of Revenue | 1.29% | 2.05% | 0.09% | 1.7% | 0.08% | 4.63% | 6.13% | 10.48% | 0.83% | 4.98% | 0.16% | 5.29% |
| Acquisitions | 0 | -10.25K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -215.49K | -110.25K | -331.78K | -204.53K | -87.4K | -153.59K | 432.31K | -605.8K | -651.59K | 28.49K | 34.75K |
| Cash from Financing | 0 | 724.5K | 75.54K | 3.61M | 355.3K | 2.05M | 1.95M | -28.58K | 5.4M | -30.52K | -63.57K | 4.06M |
| Debt Issued (Net) | 0 | 0 | 0 | -58.38K | -17.16K | 435.79K | -29.66K | -28.58K | -29.61K | -32.87K | -29.25K | -32.39K |
| Equity Issued (Net) | 0 | 724.5K | 0 | 3.67M | 355.3K | 1.62M | 1.9M | 0 | 5.38M | 2.35K | -34.31K | 4.09M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.14M | 0 | -34.32K | 0 |
| Other Financing | 0 | 0 | 75.54K | 0 | 17.16K | 0 | 87.85K | -28.58K | 45K | -32.87K | 0 | 1.16K |
| Net Change in Cash | -2.21M | -183.13K | -998.88K | 2.18M | -1.56M | -2.52M | 698.91K | -5.93M | 1.14M | -2.55M | -883.35K | 435.27K |
| Free Cash Flow | -2.08M | -845.76K | -761.94K | -1.82M | -1.91M | -3.85M | -1.97M | -5.15M | -3.88M | -2.99M | -469.08K | -4.07M |
| FCF Margin % | -25.68% | -9.86% | -8.09% | -19.38% | -21.42% | -40.09% | -23.31% | -55.36% | -51.52% | -38.98% | -7.87% | -73.23% |
| FCF Growth % | -8.93% | 78.01% | 61.25% | 64.59% | 50.91% | -28.5% | -319.14% | -26.47% | -91.52% | -22.65% | 58.26% | -609.7% |
| FCF per Share | -4.23 | -2.03 | -1.64 | -81.12 | -7.06 | -14.91 | -15.51 | -1035.59 | -1211.40 | -2507.00 | -365.04 | -32.12 |
| FCF Conversion (FCF/Net Income) | 1.67x | 0.75x | 0.82x | 0.72x | 1.44x | 1.58x | 1.13x | 9.26x | 2.48x | 2.15x | 0.70x | 4.19x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | -373.53K | 0 | 0 | 956.01K | 0 | 0 | 0 |